FormaPath Introduces Mini nToto at Annual Meeting
FormaPath made a significant announcement during the College of American Pathologists Annual Meeting with the introduction of their latest technology—a desktop version of their nToto automated tissue biopsy grossing system. This innovative device is designed to streamline the biopsy process in laboratory settings.
Event Highlights and Product Demonstration
The annual meeting is a prominent gathering for professionals in the pathology field, providing opportunities for continuing medical education and networking among experts. Attendees were able to experience firsthand the capabilities of FormaPath's miniature nToto system, which focuses on enhancing efficiency in handling small gastrointestinal biopsies.
Revolutionizing Biopsy Processing
Previously unveiled in prototype form, the nToto system integrates advanced robotics and computer vision technologies to automate the transfer of small biopsy samples from jars into cassettes. Alongside this, it generates images and textual descriptions, which can be incorporated into gross reports through Laboratory Information System integration. The device maintains a compact footprint similar to standard grossing stations while automating the processing of up to 24 jars per hour.
Impact of nToto on Laboratory Operations
Grossing, the process of performing macroscopic evaluations on tissue specimens—is crucial for accurate diagnostics. This procedure typically involves a detailed visual inspection, measurement, inking when necessary, and sectioning the tissue for further analysis. FormaPath envisions the advancement of hands-free grossing through the unique capabilities of the mini nToto system.
Collaboration and Validation
Developed in partnership with a leading advanced diagnostics laboratory, the nToto system is currently undergoing comprehensive clinical validation. This collaboration aims to ensure that the technology meets the high standards required for practical and clinical applications.
Future Plans for nToto
FormaPath is excited to soon commence in-lab demonstrations of the desktop nToto. They anticipate a product launch aimed for the summer of 2025, promising to enhance laboratories' operational efficiency significantly.
About FormaPath
Focused on transforming the cancer staging process, FormaPath is dedicated to delivering cutting-edge laboratory automation. Their mission is to improve patient care by streamlining diagnostic workflows. By minimizing human error, their technology facilitates rapid and accurate sample processing, substantially reducing turnaround times and increasing overall laboratory efficiency.
Through a commitment to research and constant innovation, FormaPath seeks to empower healthcare professionals with advanced solutions, enabling them to make informed decisions and ultimately provide patients with the best chances of positive outcomes.
Frequently Asked Questions
What is the nToto system?
The nToto system is an automated tissue biopsy grossing system designed to facilitate the processing of small biopsies efficiently.
How does nToto enhance laboratory operations?
It automates the transfer of biopsy samples and generates necessary reports, reducing manual errors and improving processing speed.
When can clients expect to see nToto in labs?
FormaPath plans to start in-lab demonstrations in the near future, with a commercial launch expected in the summer of 2025.
Who collaborated on the nToto project?
FormaPath collaborated with an advanced diagnostics laboratory to develop nToto, ensuring high standards for clinical validation.
What is FormaPath's commitment?
FormaPath is committed to revolutionizing cancer diagnostics through innovative automation, improving efficiency and accuracy in laboratories.
